A review of the use of fluticasone furoate since its launch

Bibliography

• Hansel F. Clinical and histopathologic studies of the nose and sinuses in allergy. J Allergy 1929;1:43-70
   Google Scholar
• Bauchau V, Durham SR. Prevalence and rate of diagnosis of allergic rhinitis in Europe. Eur Respir J 2004;24:758-64
   PubMed Web of Science ®Google Scholar
• Emanuel MB. Hay fever, a post industrial revolution epidemic: a history of its growth during the 19th century. Clin Allergy 1988;18:295-304
   PubMedGoogle Scholar
• Van Cauwenberge P, Watelet JB, Van Zele T, Spreading excellence in allergy and asthma: the GA2 LEN (Global Allergy and Asthma European Network) project. Allergy 2005;60:858-64
   PubMed Web of Science ®Google Scholar
• International Consensus Report on Diagnosis and Management of Rhinitis. International Rhinitis Study Management Working Group. Allergy. 1994;49(Suppl 19):1-34
   Google Scholar
• Dykewicz MS, Fineman S. Executive summary of joint task force practice parameters on diagnosis and management of rhinitis. Ann Allergy Asthma Immunol 1998;81:463-8
   PubMed Web of Science ®Google Scholar
• Van-Cauwenberge P, Bachert C, Passalacqua G, Consensus statement on the treatment of allergic rhinitis. EAACI Position paper. Allergy 2000;55:116-34
   PubMed Web of Science ®Google Scholar
• Compalati E, Ridolo E, Passalacqua G, The link between allergic rhinitis and asthma: the united airways disease. Expert Rev Clin Immunol 2010;6:413-23
   PubMed Web of Science ®Google Scholar
• Baiardini I, Braido F, Bonini M, Why do doctors and patients not follow guidelines? Curr Opin Allergy Clin Immunol 2009;9:228-33
   PubMed Web of Science ®Google Scholar
• Bousquet J, Van Cauwenberge P, Khaltaev N, Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001;108(Suppl):S147-334
   PubMed Web of Science ®Google Scholar
• Stevenson DD, Szczeklik A. Clinical and pathologic perspectives on aspirin sensitivity and asthma. J Allergy Clin Immunol 2006;118:773-86
   PubMed Web of Science ®Google Scholar
• Graf P. Rhinitis medicamentosa: a review of causes and treatment. Treat Respir Med 2005;4:21-9
   PubMedGoogle Scholar
• Settipane GA, Klein DE. Non Allergic rhinitis: demography of eosinophils in nasal smear blood total eosinophil count and IgE levels. N Euge Ref Allergy Proc 1985;6(13):363-6
   PubMedGoogle Scholar
• Shusterman D, Balmes J, Avila PC, Chlorine inhalation produces nasal congestion in allergic rhinitics without mast cell degranulation. Eur Respir J 2003;21:652-7
   PubMed Web of Science ®Google Scholar
• Bousquet J, Metcalfe D, Warner J. Food allergy. Report of the Codex Alimentarius. ACI Int 1997;9:10-21
   Google Scholar
• Bascom R, Kesavanathan J, Fitzgerald TK, Sidestream tobacco smoke exposure acutely alters human nasal mucociliary clearance. Environ Health Perspect 1995;103:1026-30
   PubMed Web of Science ®Google Scholar
• Shapiro GG, Rachelefsky GS. Introduction and definition of sinusitis. J Allergy Clin Immunol 1992;90:417-18
   PubMed Web of Science ®Google Scholar
• Wilson DR, Lima MT, Durham SR. Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis. Allergy 2005;60:4-12
   PubMed Web of Science ®Google Scholar
• Weiner JM, Abramson MJ, Puy RM. Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomized controlled trials. BMJ 1998;317:1624-9
   PubMed Web of Science ®Google Scholar
• Bousquet J, Khaltaev N, Cruz AA, Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 2008;63(Suppl 86):8-160
   PubMed Web of Science ®Google Scholar
• Brozek JL, Bousquet J, Baena-Cagnani CE, Global Allergy and Asthma European Network; Grading of Recommendations Assessment, Development and Evaluation Working Group. Allergic rhinitis and its impact on asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Immunol 2010;126:466-76
   PubMed Web of Science ®Google Scholar
• Schunemann HJ, Jaeschke R, Cook DJ, An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations. Am J Respir Crit Care 2006;174:605-14
   PubMed Web of Science ®Google Scholar
• Biggadike K, Bledsoe RK, Hassell AM, X-ray crystal structure of the novel enhanced-affinity glucocorticoid agonist fluticasone furoate in the glucocorticoid receptor-ligand binding domain. J Med Chem 2008;51:3349-52
   PubMed Web of Science ®Google Scholar
• Salter M, Biggadike K, Clackers M, GW685698X-enhanced affinity for the glucocorticoid receptor: cellular and in vivo pharmacology [abstract no. 781]. Presented at the 25th Congress of the European Academy of Allergology and Clinical Immunology, 10 – 14 June 2006, Vienna, Austria
   Google Scholar
• Baumann D, Bachert C, Hogger P. Dissolution in nasal fluid, retention and anti-inflammatory activity of fluticasone furoate in human nasal tissue ex vivo. Clin Exp Allergy 2009;39:1540-50
   PubMed Web of Science ®Google Scholar
• McCormack PL, Scott LJ. Fluticasone furoate intranasal use in allergic rhinitis. Drugs 2007;67:1905-15
   PubMed Web of Science ®Google Scholar
• Salter M, Biggadike K, Matthews JL, Pharmacological properties of the enhanced-affinity glucocorticoid fluticasone furoate in vitro and in an in vivo model of respiratory inflammatory disease. Am J Physiol Lung Cell Mol Physiol 2007;293:L660-7
   PubMed Web of Science ®Google Scholar
• Allen A, Down G, Newland A, Absolute bioavailability of intranasal fluticasone furoate in healthy subjects [Study # FFR1001]. Clin Ther 2007;29:1415-20
   PubMed Web of Science ®Google Scholar
• Martin BG, Ratner PH, Hampel FC, Optimal dose selection of fluticasone furoate nasal spray for the treatment of seasonal allergic rhinitis in adults and adolescents. Allergy Asthma Proc 2007;28:216-25
   PubMed Web of Science ®Google Scholar
• Fokkens WJ, Jogi R, Reinartz S, Once daily fluticasone furoate nasal spray is effective in seasonal allergic rhinitis caused by grass pollen. Allergy 2007;62:1078-84
   PubMed Web of Science ®Google Scholar
• Kaiser HB, Naclerio RM, Given J, Fluticasone furoate nasal spray: a single treatment option for the symptoms of seasonal allergic rhinitis. J Allergy Clin Immunol 2007;119:1430-7
   PubMed Web of Science ®Google Scholar
• Jacobs R, Martin B, Hampel F, Effectiveness of fluticasone furoate 110 mg once daily in the treatment of nasal and ocular symptoms of seasonal allergic rhinitis in adults and adolescents sensitized to mountain cedar pollen. Curr Med Res Opin 2009;25:1393-401
   PubMed Web of Science ®Google Scholar
• Vasar M, Houle PA, Douglass JA, Fluticasone furoate nasal spray: effective monotherapy for symptoms of perennial rhinitis in adults/adolescents. Allergy Asthma Proc 2008;29:313-21
   PubMed Web of Science ®Google Scholar
• Nathan RA, Berger W, Yang W, Effect of once-daily fluticasone furoate nasal spray on nasal symptoms in adults and adolescents with perennial allergic rhinitis. Ann Allergy Asthma Immunol 2008;100:497-505
   PubMed Web of Science ®Google Scholar
• Meltzer EO, Tripathy I, Lee J, Efficacy and safety of once-daily fluticasone furoate nasal spray in children with seasonal allergic rhinitis treated for 2 wk. Pediatr Allergy Immunol 2009;20:279-86
   PubMed Web of Science ®Google Scholar
• Maspero JF, Rosenblut A, Finn A, Safety and efficacy of fluticasone furoate in pediatric patients with perennial allergic rhinitis. Otolaryngol Head Neck Surg 2008;138:30-7
   PubMed Web of Science ®Google Scholar
• Maspero JF, Walters RD, Wu W, An integrated analysis of the efficacy of fluticasone furoate nasal spray on individual nasal and ocular symptoms of seasonal allergic rhinitis. Allergy Asthma Proc 2010;31:483-92
   PubMed Web of Science ®Google Scholar
• Zieglmayer P, Zieglmayer R, Bareille P, Fluticasone furoate versus placebo in symptoms of grass-pollen allergic rhinitis induced by exposure in the Vienna Challenge Chamber. Curr Med Res Opin 2008;24:1833-40
   PubMed Web of Science ®Google Scholar
• Given JT, Cheema AS, Dreykluft T, Fluticasone furoate nasal spray is effective and well tolerated for perennial allergic rhinitis in adolescents and adults. Am J Rhinol Allergy 2010;24:444-50
   PubMed Web of Science ®Google Scholar
• Rodrigo GJ, Neffen H. Efficacy of fluticasone furoate nasal spray vs. placebo for the treatment of ocular and nasal symptoms of allergic rhinitis: a systematic review. Clin Exp Allergy 2011;41:160-70
   PubMed Web of Science ®Google Scholar
• Okubo K, Nakashima M, Miyake N, Dose-ranging study of fluticasone furoate nasal spray for Japanese patients with perennial allergic rhinitis. Curr Med Res Opin 2008;24:3393-403
   PubMed Web of Science ®Google Scholar
• Baroody FM, Shenaq D, DeTineo M, Fluticasone furoate nasal spray reduces the nasal-ocular reflex: a mechanism for the efficacy of topical steroids in controlling allergic eye symptoms. J Allergy Clin Immunol 2009;123:1342-8
   PubMed Web of Science ®Google Scholar
• Keith PK, Scadding GK. Are intranasal corticosteroids all equally consistent in managing ocular symptoms of seasonal allergic rhinitis? Curr Med Res Opin 2009;25:2021-41
   PubMed Web of Science ®Google Scholar
• Andrews CP, Martin BG, Jacobs RL, Fluticasone furoate nasal spray is more effective than fexofenadine for nighttime symptoms of seasonal allergy. Allergy Asthma Proc 2009;30:128-38
   PubMed Web of Science ®Google Scholar
• Okubo K, Nakashima M, Miyake N, Comparison of fluticasone furoate and fluticasone propionate for the treatment of Japanese cedar pollinosis. Allergy Asthma Proc 2009;30:84-94
   PubMed Web of Science ®Google Scholar
• Meltzer EO, Andrews C, Journeay GE, Comparison of patient preference for sensory attributes of fluticasone furoate or fluticasone propionate in adults with seasonal allergic rhinitis: a randomized, placebo-controlled, double-blind study. Ann Allergy Asthma Immunol 2010;104:331-8
   PubMed Web of Science ®Google Scholar
• Patel D, Ratner P, Clements D, Lack of effect on adult and adolescent hypothalamic-pituitary-adrenal axis function with use of fluticasone furoate nasal spray. Ann Allergy Asthma Immunol 2008;100:490-6
   PubMed Web of Science ®Google Scholar
• Meltzer EO, Tripathy I, Maspero JF. Safety and tolerability of fluticasone furoate nasal spray once daily in paediatric patients aged 6 – 11 years with allergic rhinitis. subanalysis of three randomized, double-blind, placebo-controlled, multicentre studies. Clin Drug Invest 2009;29:79-86
   PubMed Web of Science ®Google Scholar
• Gradman J, Caldwell MF, Wolthers OO. A 2-week, crossover study to investigate the effect of fluticasone furoate nasal spray on short-term growth in children with allergic rhinitis. Clin Ther 2007;29:1738-47
   PubMed Web of Science ®Google Scholar
• Rosenblut A, Bardin PG, Muller B, Long-term safety of fluticasone furoate nasal spray in adults and adolescents with perennial allergic rhinitis. Allergy 2007;62:1071-7
   PubMed Web of Science ®Google Scholar
• Fokkens W, Hellings P, Blom J, A comparison of the effects of fluticasone furoate and mometasone furoate nasal sprays on the nasal mucosa [Study FFR104503; abstract no. 36]. Ann Allergy Asthma Immunol 2008;100:A12
   PubMed Web of Science ®Google Scholar